{"id":"W4410221641","doi":"10.1016/j.cjca.2025.04.028","title":"Dual Antiplatelet Therapy in Cancer Patients Undergoing Revascularization: Which Second Agent to Use? Reply","year":2025,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dual (grammatical number); Revascularization; Internal medicine; Cancer; Oncology; Cardiology; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002285952,0.0007141403,0.001825367,0.001139623,0.003692739,0.003536374,0.001361094,0.05920598,0.005966643],"category_scores_gemma":[0.02577358,0.0007795054,0.001243363,0.001161458,0.001956051,0.002285883,0.001311327,0.03828772,0.004051072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005463229,"about_ca_system_score_gemma":0.006868011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01818376,"about_ca_topic_score_gemma":0.02799679,"domain_scores_codex":[0.997698,0.0006040048,0.0004738389,0.0002615807,0.0005278883,0.0004347435],"domain_scores_gemma":[0.9881623,0.006247838,0.0009217578,0.0002314539,0.002129916,0.002306702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009844652,0.00004520598,0.002615922,0.00009222714,0.00003249383,0.003792911,0.0001973932,0.000108788,0.0001335573,0.001324227,0.9835082,0.008050603],"study_design_scores_gemma":[0.000467997,0.0002428498,0.007097615,0.001210399,0.0002372991,0.009632171,0.00162575,0.001462443,0.000394713,0.009150648,0.9682274,0.0002508056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0004588221,0.0008804071,0.00004318986,0.9860592,0.01104203,0.000009235536,0.00005181138,0.00001106686,0.001444264],"genre_scores_gemma":[0.005419517,0.001450848,0.0001996791,0.9505008,0.03931664,0.00003795599,0.00004915132,0.00001386589,0.00301159],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05920598,"threshold_uncertainty_score":0.0396387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02074132455989569,"score_gpt":0.2510136980412955,"score_spread":0.2302723734813998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}